Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784323 · ClinicalTrials.gov registry record · NA
Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
A NA study of Ulcerative Colitis, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 122
- Enrollment target
- 1
- Study location
NCT06784323 is a NA study of Ulcerative Colitis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 122 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06784323, a NA study of Ulcerative Colitis, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.
Conditions Studied
Interventions
- BEHAVIORAL Catered diet
- BEHAVIORAL Diet guidance sessions
- BEHAVIORAL Dietary counseling
- BEHAVIORAL Feedback sessions
Study Locations (1)
Florida
- University of Miami Health System - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2025-03-05 |
| Est. Completion | 2030-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06784323
The ClinicalTrials.gov registry entry for NCT06784323 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 4 interventions - of which Catered diet is the first listed.
NCT06784323 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06784323 about?
NCT06784323 is a clinical study titled "Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)". The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.
What is the current status of trial NCT06784323?
This trial is currently recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2025-03-05. Estimated completion is 2030-09-01.
What conditions does trial NCT06784323 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
What interventions are being tested in trial NCT06784323?
The interventions under investigation include: Catered diet (BEHAVIORAL), Diet guidance sessions (BEHAVIORAL), Dietary counseling (BEHAVIORAL), Feedback sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06784323?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784323 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
-
Fermented Food-Supplemented Diet in Ulcerative Colitis
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
BOOM-IBD2 Pivotal Clinical Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.